Sanofi Revises Down 3Q 2015 Sales Figure to EUR9.46 Billion From EUR9.59 Billion Previously
October 12 2016 - 03:46AM
Dow Jones News
By Inti Landauro
PARIS--French pharmaceutical giant Sanofi SA (SAN.FR) Wednesday
revised down its sales figure for the third quarter last year,
ahead of the release of earnings for the third quarter of this year
on Oct. 28
The company said its aggregate sales in the third quarter of
last year were 9.46 billion euros ($10.30 billion), down from
EUR9.59 billion reported previously. The company said it had
reclassified EUR136 million in VaxServe product sales from other
manufacturers.
The earnings to be released on Oct. 28 will include a $100
million charge due to a settlement in litigation with Cipro
generic. The charge will be reported in the line "other current
operating income/expenses," the company said.
Write to Inti Landauro at inti.landauro@wsj.com
(END) Dow Jones Newswires
October 12, 2016 03:31 ET (07:31 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
Sanofi (NASDAQ:SNY)
Historical Stock Chart
From Feb 2024 to Mar 2024
Sanofi (NASDAQ:SNY)
Historical Stock Chart
From Mar 2023 to Mar 2024